We have investigated the effects of decreased levels of the complex between glycoprotein VI (GPVI) and the Fc receptor γ-chain (FcRγ) on responses to collagen and GPVI-specific ligands in murine platelets. We show that levels of GPVI—FcRγ of the order of 50% and 20% of wild-type levels caused 2- and 5-fold shifts to the right respectively in the dose—response curve for aggregation in response to collagen, the snake toxin convulxin and the monoclonal antibody JAQ1. In addition, there is a delay in the onset of aggregation in response to collagen. In contrast, the stimulation of protein tyrosine phosphorylation by collagen (as measured after 150s) and adhesion to a collagen-coated surface under static conditions were unaffected in platelets with 50% and 20% of wild-type levels of GPVI. In contrast, responses to a collagen-related peptide (CRP), made up of repeat glycine-proline-hydroxyproline motifs, were markedly inhibited and abolished in platelets expressing 50% and 20% of wild-type levels of GPVI respectively. We suggest that the marked effect of a reduction in GPVI levels on the CRP-induced activation of platelets is due to the multivalent nature of CRP and the fact that GPVI is its sole receptor on platelets. Thus it appears that the interaction of CRP with GPVI is determined by a combination of affinity and avidity. The observation that collagen does not behave like CRP in platelets expressing reduced levels of GPVI, even in the combined presence of blocking antibodies against integrin α2β1 and GPV, suggests that collagen has a greater affinity than CRP for GPVI, and/or that other receptors are involved in its binding to platelets. The clinical significance of these results is discussed.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
November 2002
- PDF Icon PDF LinkFront Matter
Research Article|
November 15 2002
Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands Available to Purchase
Daniel C. SNELL;
Daniel C. SNELL
1
∗Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K.
Search for other works by this author on:
Valerie SCHULTE;
Valerie SCHULTE
1
†Department of Molecular Oncology, General Surgery, Witten/Herdecke University, 42117 Wuppertal, Germany,
2To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
Gavin E. JARVIS;
Gavin E. JARVIS
∗Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K.
Search for other works by this author on:
Kanako ARASE;
Kanako ARASE
‡Department of Molecular Genetics (H1), Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
Search for other works by this author on:
Daiju SAKURAI;
Daiju SAKURAI
‡Department of Molecular Genetics (H1), Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
Search for other works by this author on:
Takashi SAITO;
Takashi SAITO
‡Department of Molecular Genetics (H1), Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
Search for other works by this author on:
Steve P. WATSON;
Steve P. WATSON
2
∗Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K.
2To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
Bernhard NIESWANDT
Bernhard NIESWANDT
†Department of Molecular Oncology, General Surgery, Witten/Herdecke University, 42117 Wuppertal, Germany,
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
February 27 2002
Revision Received:
June 10 2002
Accepted:
July 15 2002
Accepted Manuscript online:
July 15 2002
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London ©2002
2002
Biochem J (2002) 368 (1): 293–300.
Article history
Received:
February 27 2002
Revision Received:
June 10 2002
Accepted:
July 15 2002
Accepted Manuscript online:
July 15 2002
Citation
Daniel C. SNELL, Valerie SCHULTE, Gavin E. JARVIS, Kanako ARASE, Daiju SAKURAI, Takashi SAITO, Steve P. WATSON, Bernhard NIESWANDT; Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands. Biochem J 15 November 2002; 368 (1): 293–300. doi: https://doi.org/10.1042/bj20020335
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |